Pharmacogenetics of acute lymphoblastic leukemia treatment response (Q36968156)

17 August 2017

1 reference

title

Pharmacogenetics of acute lymphoblastic leukemia treatment response (English)

1 reference

17 August 2017

main subject

lymphoblastic leukemia

1 reference

Lea Cunningham

1

1 reference

17 August 2017

Richard Aplenc

series ordinal

2

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

15

1 reference

17 August 2017

page(s)

2519-2531

1 reference

Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Pharmacogenetics and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Building better therapy for children with acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Genetic polymorphism of thiopurine S-methyltransferase in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Phenotypic and Genotypic Analysis of Thiopurine S-Methyltransferase Polymorphism in the Bulgarian Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Recent advances in the pharmacogenomics of thiopurine methyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Thiopurine S-methyltransferase genetic polymorphism in the Thai population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Thiopurine methyltransferase in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

High incidence of secondary brain tumours after radiotherapy and antimetabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Mistaken identity: misclassification of TPMT phenotype following blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Closing the gap between science and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Homocysteine, pharmacogenetics, and neurotoxicity in children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

No evidence of association of methylenetetrahydrofolate reductase polymorphism with occurrence of second neoplasms after treatment of childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Polymorphisms of genes controlling homocysteine levels and IQ score following the treatment for childhood ALL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Ethnic variation in the thymidylate synthase enhancer region polymorphism among Caucasian and Asian populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

The influence of cyclin D1 (CCND1) 870A>G polymorphism and CCND1-thymidylate synthase (TS) gene-gene interaction on the outcome of childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Genetic polymorphism (G80A) of reduced folate carrier gene in ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Cytochrome P450 and anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Cytochrome P450s and other enzymes in drug metabolism and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Cytochrome P450 pharmacogenetics and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Genetic variability in CYP3A5 and its possible consequences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

CYP3A4 polymorphisms - potential risk factors for breast and prostate cancer: a huge review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Association of CYP3A4 genotype with treatment-related leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Glutathione S-transferase P1 genetic polymorphisms and susceptibility to childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Mammalian class theta GST and differential susceptibility to carcinogens: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

GSTP1 and MDR1 genotypes and central nervous system relapse in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

GST polymorphisms and occurrence of second neoplasms after treatment of childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Frequency of C3435T polymorphism of MDR1 gene in African people

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Influence of functional polymorphisms of the MDR1 gene on vincristine pharmacokinetics in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

The MIF-173G/C polymorphism does not contribute to prednisone poor response in vivo in childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.15.2519

10.1517/14656566.8.15.2519

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference